A comparative solubility enhancement profile of valdecoxib with different solubilization approaches

Indian Journal of Pharmaceutical Sciences

Volumn 69, Issue 2, 2007, Pages 274-278

  Modi, A ^b   Tayade, P ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

^b HK College of Pharmacy   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; BETA CYCLODEXTRIN SULFOBUTYL ETHER; CASTOR OIL; CETOMACROGOL; CETRIMIDE; CREMOPHOR; CYCLOOXYGENASE 2 INHIBITOR; DODECYL SULFATE SODIUM; HYDROCARBON; IONIC SURFACTANT; MACROGOL; MACROGOL 400; MACROGOL 600; NONIONIC SURFACTANT; POLIDOCANOL; POLOXAMER; POLYSORBATE 80; SOLVENT; UNCLASSIFIED DRUG; VALDECOXIB; WATER;

AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; DRUG SOLUBILITY; HYDROPHILICITY; INTERMETHOD COMPARISON; MICELLE; SOLUBILIZATION;

EID: 34347371491     PISSN: 0250474X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0250-474x.33156     Document Type: Article

References (18)

1. Atwood D, Florence AT. Surfactant systems. Chapman and Hall: London; 1983.
2. Yalkowsky SH, editors. Techniques of solubilization. Marcel Dekker Inc: New York; 1983.
3. rd ed. Lea and Febiger: Philadelphia; 1993.
4. Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 1996;85:1017-25.
5. Rajewski RA, Stella, VJ. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J Pharm Sci 1996;85:1142-69.
6. Szente L, Szejtli J. Highly soluble cyclodextrin derivatives: properties and trends in development. Adv Drug Deliv Rev 1999;36:17-28.
7. Li P, Zhao L, Yalkowsky SH. Combined effect of cosolvent and cyclodextrin on solubilization of nonpolar drugs. J Pharm Sci 1999;88:1107-11.
8. Loftsson T, Petersen DS. Cyclodextrin solubilization of ETH-615, A zwitterionic drug. Drug Develop Ind Pharm 1998;24:365-70.
9. Chavez ML, DeKorte CJ. Valdecoxib: A review. Clin Ther 2003;25:817-51.
10. Sheu M, Chen S, Chen L, Ho H. Influence of micelle solubilization by tocopheryl polyethylene glycol succinate (TPGS) on solubility enhancement and percutaneous penetration of estradiol. J Control Release 2003;88:355-68.
11. Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem Instrum 1965;4:117.
12. Ikeda K, Tomida H, Yotsuyanagi T. Micellar interaction of tetracycline antibiotics. Chem Pharm Bull 1977;25:1067-72.
13. Zhao L, Li P, Yalkowsky SH. Solubilization of fluasterone. J Pharm Sci 1999;88:967-9.
14. Moro ME, Velazquez MM, Cachaza JM, Rodriguez LJ. Solubility of diazepam and prazepam in aqueous non-ionic surfactants. J Pharm Pharmacol 1986;38:294-6.
15. Connors KA. The stability of cyclodextrin complexes in solution. Chem Rev 1997;97:1325-58.
16. Nagase Y, Suzuki N, Yamauchi H. Kim S, Wada K, Arima H, et al. Inclusion complexation of a selenoorganic antioxidant ebselen with cyclodextrin in aqueous solution. J Incl Phenom Macro Chem 2002;44:107.
17. Yalkowsky SH, Flynn GL, Amidon GL. Solubility of nonelectrolytes in polar solvents. J Pharm Sci 1972;61:983-4.
18. Yalkowsky SH, Rubino JT. Solubilization by cosolvents 1: Organic solutes in propylene glycol-water mixtures. J Pharm Sci 1985;74:416-21.